Below are MBC trials that have been added to BreastCancerTrials.org (BCT) in the last month. These trials can also be found on Metastatic Trial Search (MTS)
Stage IV Triple-Negative Trials
- LY3435151 Alone or With Pembrolizumab in Advanced Triple Negative Breast Cancer
- Talazoparib in Women With Metastatic TNBC or HR+, HER2- Breast Cancer With A Somatic (Not Inherited) BRCA1/2 Mutation
Stage IV HR Positive (HR+) Trials
- Immunotherapy DF1001 Alone or With Keytruda® for IHC HER2 1+, 2+ or 3+ Metastatic Breast Cancer
- Niraparib and Herceptin in Women With Metastatic HER2+ Breast Cancer
- LY3484356 Alone or With Abemaciclib in Advanced ER+, HER2- Breast Cancer
- ZN-C5 for Stage I, II, III, and IV ER+, HER2- Breast Cancer
- Your Hormone Therapy & GMI-1359 in Hormone Positive Metastatic Breast Cancer
- Talazoparib in Women With Metastatic TNBC or HR+, HER2- Breast Cancer With A Somatic (Not Inherited) BRCA1/2 Mutation
Stage IV BRCA Positive Trials
- NMS-03305293 in Advanced HER2 Negative Breast Cancer in People with a Hereditary BRCA Mutation
- PARP Inhibitor Rucaparib in Advanced Breast Cancer That Tests Positive for BRCA or Other Mutations
- Talazoparib in Women With Metastatic TNBC or HR+, HER2- Breast Cancer With A Somatic (Not Inherited) BRCA1/2 Mutation
Stage IV Mutation Specific Trials
- BDTX-189 in Metastatic Breast Cancer That Tests Positive for Certain Markers (Mutations)
- eFT226 in Advanced Breast Cancer That Tests Positive for HER2, ERBB3, FGFR1, FGFR2, or KRAS Mutations
Other Stage IV Trials
- The Targeted Therapy LY3475070 Alone or With Pembrolizumab in Advanced Breast Cancer
- IMX-110 for Advanced Breast Cancer
Use Metastatic Trial Search to find all metastatic breast cancer trials that are right for you.
Last Modified on April 9, 2021
